known to have become opaque. The commonest causes of graft opacification were bacterial keratitis (6.0%), endothelial failure (6.0%), and graft rejection (5.1%). Preoperatively 55% ofkeratoconus eyes and 75.7% of non-keratoconus eyes were blind. Postoperatively, 5% of keratoconus eyes and 41.7% of the nonkeratoconus eyes were blind. Normal vision was achieved in 53.7% of operated eyes. Grafts carried out for keratoconus had a better visual outcome than grafts performed for other corneal pathologies. Preoperatively, 12.4% of keratoconus and 48.5% of non-keratoconus patients were blind in their better eye. Postoperatively, 1.1% of keratoconus patients and 25.7% of non-keratoconus patients were blind. The number of patients with normal vision in the better eye increased from 32 (17.2%) to 106 (57.0%). Sight was restored to 34 blind patients, but two patients with severe visual impairment preoperatively were blind at their last follow up. There was therefore a net reduction of 32 in the number of blind patients after 216 keratoplasties. Conclusions-Penetrating keratoplasty can be successful in Africa, particularly for keratoconus and other corneal dystrophies. However, penetrating keratoplasty has a limited role in the treatment of blindness from corneal scarring due to trachoma, measles, and vitamin A deficiency for which community based preventive measures must remain the priority.
(BrJ7 Ophthalmol 1996;80:890-894)
The prognosis for penetrating keratoplasty in the industrialised world has improved greatly during the past 20 years. However, relatively little is known about the effectiveness and role of penetrating keratoplasty in countries of the developing world, particularly sub-Saharan Africa.' In the UK, corneal blindness accounts for 2% of Time (months) Figure 1 Probability ofgraft survival in 108 penetrating keratoplasties for keratoconus and 108 penetrating keratoplasties for other corneal pathologies.
and had not attended the clinic for 6 months; or in patients whose grafts had been performed over 3 years previously, if they had not attended for 12 months. Altogether 56 (27.6%) eyes were lost to follow up, of which 35 attended for at least 6 months with a clear graft, but had not been seen during the last 6-12 months. All grafts were included in the calculation of graft survival.
GRAFF SURVIVAL
The probability of graft survival was determined using the method of Kaplan and Meier. Grafts lost to follow up were treated as censored data, and survival time was taken from their last clinic attendance. The probability of survival at 24 months among the keratoconus grafts was 87.4% (95% CI 80.6-94.3%) and in the non-keratoconus grafts 64.7% (95% CI 54.8-74.6%). The survival curve is shown in Figure 1 . The preoperative and latest postoperative visual status of both keratoconus and nonkeratoconus patients is shown in Table 5 . Before surgery, 58 patients were blind (<3/60 in the better eye). Of these the majority (81 %) were non-keratoconus patients.
CAUSE OF GRAFT OPACIFICATION
Postoperatively, 26 (14.0%) patients were blind (non-keratoconus 25.7% versus keratoconus 1.1%). A total of 34 patients who were blind preoperatively improved so that they were no longer blind after surgery. However, two patients who were not blind before surgery had become blind at their last follow up visit. Therefore, from a total of 216 penetrating keratoplasties performed, there was a net reduction in the number of blind patients of 32 .
The number of patients with normal vision increased by 74, from 32 to 106. Most of these (77.5%) were keratoconus patients. Keratoconus patients were more likely than nonkeratoconus patients to achieve normal visual status postoperatively (77.5% versus 38.1%, x2= 29.3, p<0.001).
Changes in visual status are shown in Table  6 . Ninety six patients (51.6%) had an improvement in their visual status and three patients (1.6%) had a worse visual status postoperatively. Of the keratoconus patients, 61.8% showed some improvement in their visual status as opposed to 42.3% of the nonkeratoconus patients (X'= 7.1, p<0.01). POOR VISUAL OUTCOME Fifty seven operated eyes had a latest visual acuity of <6/60 (seven keratoconus and 50 non-keratoconus). The causes of the poor visual acuities are shown in Table 7 . Graft opacification accounted for 54.4% and glaucoma 14.0%. Retinal disease was the cause in 
DIAGNOSIS
The most frequent diagnosis was keratoconus, which was the indication for grafting in 50% of the patients. The proportion of grafts performed for herpes simplex keratitis (7.8%) is higher than in recent series from Western countries,9 reflecting the greater severity of the disease in Africa,'0 and the relative unavailability of effective treatment. It is striking that only 11 out of 216 grafts were performed for the major causes of corneal blindness in Africameasles and trachoma. The grafts that were performed for measles or trachoma did badly, as six out of the 11 grafts became opaque. This suggests that penetrating keratoplasty has a very limited role in eliminating blindness from measles, vitamin A deficiency, and trachoma in Africa.
DONOR MATERIAL
It was encouraging to see that out of 210 grafts using overseas material, there were only six cases (3%) of primary graft failure. This confirms that it is possible to send donor corneas thousands of kilometres from their place of origin.
GRAFT SURVIVAL Overall survival rates were lower than those reported from developed countries."-" In most of these series, the 2 year survival rate for keratoconus grafts was well over 90% compared with 87% in our series. Among the keratoconus grafts, the younger age of the patients, and the coexisting severe vernal disease may play a part in reducing graft survival. If the five keratoconus grafts that failed because of primary graft failure are excluded, the 2 year survival improves to 91.7%.The overall rate of 64.7% survival of non-keratoconus grafts at 2 years is lower than would be expected in an industrialised country.
The major reason for the poorer prognosis is inadequate follow up. Nearly one third of patients with corneal grafts that were clear at their last follow up visit are no longer attending the clinic. Failure to attend for follow up, despite intensive preoperative counselling, is due to the cost involved in travelling to attend the clinic, and different cultural attitudes to health and disease leading to poor patient compliance. GRAFT FAILURE Suppurative keratitis was the leading cause of graft failure. The incidence of infection (15.7%) is much higher than reported in the UK. '5 Suppurative keratitis was associated with loose sutures, increasing age, and preoperative diagnosis of bacterial keratitis or trachoma. Secondary endothelial failure often followed traumatic wound dehiscence or wound leaks. Acute rejection was more likely to lead to graft failure in non-keratoconus grafts than in keratoconus grafts. All patients received topical steroids for at least 6 months after surgery.
VISUAL ACUITY
The preoperative visual acuities tended to be worse in the non-keratoconus eyes. This may reflect the fact that keratoconus rarely reduces the vision to hand motions. It is also likely that there is some bias, as the known better prognosis for keratoconus grafts probably encouraged earlier surgery in these patients. The final visual acuities are lower than reported for most other series, particularly for keratoconus eyes." 12 This is partly because of the higher graft failure rate in our series, but may also be due to the fact that in other series 20-37% of the patients were at least partly reliant on contact lens correction in order to obtain good visual acuity." In a large multicentre prospective study of corneal grafts in the UK, 47% of eyes at 3 months and 61% at 12 months had a visual acuity of 6/18 or better'2; this compares with 73% for keratoconus eyes and 35% for non-keratoconus eyes in the present study. The latest visual acuity in the operated eye was worse than the vision in the unoperated eye in 13.8% of eyes. This compares with 48.3% in the series from Australia.'6 This figure is likely to be an important factor in determining patient satisfaction with his or her graft.
ASTIGMATISM
We found that the mean astigmatism was significantly greater in keratoconus eyes than non-keratoconus eyes with an average astigmatism of 4.2 D for the keratoconus patients. Less than a quarter (23.3%) of all eyes had a cylinder greater than 5 dioptres. As contact lenses are expensive and difficult to obtain in Kenya, astigmatism was usually managed with spectacles.
POOR VISUAL OUTCOME Fifty seven eyes (28%) had a postoperative visual acuity of less than 6/60. The commonest cause of poor vision was graft opacity (31 of 57 eyes). This indicates that the most effective way of improving visual outcome will be to improve graft survival. The causes of poor acuity with a clear graft are similar to those reported in other series' although the numbers affected are proportionately greater.
VISUAL STATUS
The non-keratoconus patients were much more likely to be bilaterally blind preoperatively than the keratoconus patients. Only one keratoconus patient remained blind after penetrating keratoplasty, but 25 (25.7%) of the non-keratoconus patients were still blind, with a vision of <3/60 in their better eye. After the 216 penetrating keratoplasties in this series, the number of blind patients was reduced by 32-that is, an average of one in seven corneal grafts restored sight to a blind person. It is currently estimated that six million people are blind from corneal disease. 4 Compared with cataract surgery, penetrating keratoplasty is relatively ineffective at restoring sight to blind patients; however, it does result in an improved visual status in the majority of patients, which can have far reaching socioeconomic effects. Consider a teenager with keratoconus and vision of 6/60 and 2/60. He will be having serious difficulties continuing his education in a normal African school. If his vision improves to 6/12 in one eye following keratoplasty, he will be able to stay in a normal school and education system, with improved prospects for himself, and considerable savings for his community.
Conclusions
Penetrating keratoplasty in Africa is possible and, with care and attention, clear grafts can be obtained in many patients. We suggest that penetrating keratoplasty has a definite role in the treatment of keratoconus, which is nonpreventable, visually disabling, usually bilateral, occurs in young people, and in which nearly three quarters of grafted eyes obtained a postoperative visual acuity of 6/18 or better. In non-keratoconus corneal disease, we recommend that surgery should only be considered if the fellow eye has a vision of less than 6/60 and the eye for surgery is suitable for penetrating keratoplasty.
We advocate the development of selected tertiary centres for penetrating keratoplasty in Africa. These centres should focus their efforts on grafting for keratoconus and other corneal dystrophies, and should seek to change cultural attitudes to tissue donation. In view of the limited role and poor results of penetrating keratoplasty in corneal scarring due to trachoma, vitamin A deficiency, and measlescurrently the major causes of corneal blindness in Africa-priority must still be given to community health programmes including measles immunisation, improved nutrition, trachoma control, and eyelid surgery for trichiasis.
